Hikma Pharmaceuticals Plc Director/PDMR Shareholding (8929Y)
17 Maggio 2021 - 5:00PM
UK Regulatory
TIDMHIK
RNS Number : 8929Y
Hikma Pharmaceuticals Plc
17 May 2021
Hikma Pharmaceuticals PLC - EIP B and EIP C Vesting
LONDON, 17 May 2021: Hikma Pharmaceuticals PLC (LSE: HIK)
(NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces
that the following Persons Discharging Managerial Responsibility
("PDMR") have received shares as a result of the vesting of their
conditional share awards which were granted on 17 May 2019 under
the 2014 Executive Incentive Plan ("EIP") Element B and granted on
16 May 2018 under the 2014 EIP Element C. The Element B awards
vested two years after grant and the Element C awards vested three
years after grant.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Mazen Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
16 May 2021 under the EIP Element C. All Shares
were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 12,042
d) Aggregated information
* Volume 12,042
GBP0.00
GBP0.00
* Price
Total
e) Date of the transaction 17 May 2021
f) Place of the London Stock Exchange (XLON)
transaction
Riad Mishlawi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Riad Mishlawi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
16 May 2021 under the EIP Element C. All Shares
were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 22,601
d) Aggregated information
* Volume
22,601
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 May 2021
f) Place of the London Stock Exchange (XLON)
transaction
Majda Labadi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Majda Labadi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
16 May 2021 under the EIP Element C. All Shares
were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 15,855
d) Aggregated information
* Volume
15,855
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 May 2021
f) Place of the London Stock Exchange (XLON)
transaction
Bassam Kanaan
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
16 May 2021 under the EIP Element C. All Shares
were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 25,729
d) Aggregated information
* Volume
25,729
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 May 2021
f) Place of the London Stock Exchange (XLON)
transaction
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
16 May 2021 under the EIP Element C. All Shares
were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 23,062
d) Aggregated information
* Volume
23,062
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 May 2021
f) Place of the London Stock Exchange (XLON)
transaction
Susan Ringdal
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Susan Ringdal
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
16 May 2021 under the EIP Element C. Shares
were sold to cover tax and the remainder were
retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 7,522
Price(s): GBP23.835
Volume(s): 6,735
d) Aggregated information
* Volume
14,257
GBP23.835
* Price GBP160,528.73p
* Total
e) Date of the transaction 17 May 2021
f) Place of the London Stock Exchange (XLON)
transaction
Hussein Arkhagha
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Hussein Arkhagha
2 Reason for the notification
a) Position/status PDMR
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial (Shares)
instrument, type ID Code: GB00B0LCW083
of instrument
and identification
code
b) Nature of the Shares acquired from the vesting of conditional
transaction awards on
17 May 2021 under the EIP Element B. All Shares
were retained.
c) Price(s) and Price(s): GBPnil
volume(s) Volume(s): 11,246
d) Aggregated information
* Volume
11,246
GBP0.00
* Price GBP0.00
* Total
e) Date of the transaction 17 May 2021
f) Place of the London Stock Exchange (XLON)
transaction
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
17 May 2021
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHBSGDUUUBDGBR
(END) Dow Jones Newswires
May 17, 2021 11:00 ET (15:00 GMT)
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Apr 2023 a Apr 2024
